DRREDDY DR.REDDYS LABORATORIES LTD.
Healthcare
LTP
1,350.2
CHG · %
+11.7 (+0.87%)
VOL · TODAY
17.14L
PREV CLOSE
1,338.5
Today's range1,345.3 · 1,363.45
1,350.2
52-week range1,101 · 1,414.9
1,350.2
Loading candles…
Dr. Reddy's Laboratories Ltd is a pharmaceutical company operating in the pharmaceutical industry with a presence in over 83 countries globally, including the United States, India, and emerging markets. The company offers a portfolio of products and services comprising active pharmaceutical ingredients (APIs), custom pharmaceutical services (CPS), generics, biosimilars, and differentiated formulations. Its operations are organized into key segments such as Global Generics, Pharmaceutical Services and Active Ingredients (PSAI), and Others, which include proprietary products. Dr. Reddy's focuses on providing affordable and innovative medicines worldwide. No information is available regarding its incorporation year, founders, key management, subsidiaries, notable projects, or stock exchange listings.
DRREDDY is not part of any active scan today.
This page is a live market overview for DR.REDDYS LABORATORIES LTD. (DRREDDY) on the BSE. As a listed security, DR.REDDYS LABORATORIES LTD. is tracked in the Healthcare segment of the Indian cash market and is widely followed for price discovery, liquidity and sector exposure. Use this overview to review price action, session ranges and derivatives context for DRREDDY before placing trades on tick2trade.
As of the latest feed, DRREDDY last traded at ₹1,350.2 on BSE, up ₹11.7 (0.87%) from the previous close of ₹1,338.5. Today's session range is ₹1,345.3 – ₹1,363.45, against a 52-week band of ₹1,101 – ₹1,414.9. Traded volume today stands at 17.14L shares.
The overview consolidates an interactive price chart with multiple time ranges, recent market headlines, upcoming corporate events for DRREDDY in one place so you do not need multiple screens during the session. Day and 52-week ranges help you judge whether DRREDDY is trading near support, resistance or the middle of its recent band. Volume and depth, when available, add context on how aggressively the name is being bought or sold.
Equity overview pages are built for investors who want a single reference for DR.REDDYS LABORATORIES LTD. before reading news, checking results or sizing a position. Corporate events and headlines in the side column surface catalysts that may explain sudden moves in DRREDDY. Related stocks in the same sector appear at the bottom of the page for quick peer comparison.
For a full option chain with greeks, open-interest bias, max pain and multi-leg strategy tools, open the tick2trade terminal or visit the dedicated DRREDDY option chain page linked from this overview.
// similar in healthcare326 total